Published in Blood Article reference Santidrián AF* González-Gironès DM* Iglesias-Serret D* Coll-Mulet L* Cosialls AM* de Frias M* Campàs C* González-Barca E* Alonso E* Pons G Gil J*
New data validate effectiveness of a new treatment for leukaemia Read More »
Science magazine publishes this week in its Science Careers supplement an interview with Manel Esteller, director of the Epigenetics and Cancer Biology at Bellvitge Biomedical Research Institute (IDIBELL). The interview, entitled “Opening New Avenues in Epigenetics Research”, is part of the publication of a special on epigenetics in the latest issue of the magazine. Science
Manel Esteller interviewed in Science Magazine Read More »
Iasist’s Top 20 Hospitals recognizes quality, performance and efficiency
Bellvitge University Hospital, one of the best hospitals in Spain Read More »
Thus, the UB became the first and only general university of Spain which has two international excellence campuses. The UB, along with the UPC [Catalan Polithecnic University], also won this award last year with the Barcelona Knowledge Campus (BKC). HUBc Campus includes the Medicine campus of Barcelona Clinic Hospital, along with Sant Joan de Déu
HUBc, disigned campus of international excellence Read More »
Four IDIBELL researchers are involved in projects funded by La Marató de TV3 2009, dedicated to rare diseases. They are Julian Ceron, research group of chemoresistance and predictors of response and stromal tumour, Victor Volpini, research group of Neurological Disorders and Neurogenetics, David Monk, head of the group of genomic imprinting and cancer, and Ethel Queralt, head Cell Cycle Group. Julián Cerón Madrigal Victor Volpini Bertran David Monk Ethelvina Queralt Badia
La Marató de TV3 finance four projects involving IDIBELL researchers Read More »
The IDIBELL researcher receives in Berlin the World Health Summit and Pfizer Award for Innovation in Biomedical Research Manel Esteller Profile
Manel Esteller bestowed with the World Health Summit Award Read More »
